Impedance Cardiology Systems

Recent Finacing

Series B

Recent Raise

$5M

Impedance Cardiology Systems is a Menlo Park, California biotech company developing clinical cardiology devices and technologies leveraging bioimpedance measurements.

Founded 2006

California, United States

1-10

Private

Highlights

Focus Areas

Biotechnology

Health Care

Recent Investors

Financials

$5M

Total Raised

1

Funding round

2

Investors